Antibiotic Considerations in the Critically Ill
Critical Care Clinics · 2026-07 · 42 (3) · 585-609
DOI: 10.1016/j.ccc.2026.01.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Critical Care Clinics, 2026-07. Verfasst von Eric M Gillett und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA; Division of Infectious Diseases, Department of Medicine, Brigham and Women's H…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Critical Illness, Bacterial Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality.
Abstract (Originalsprache)
Treating infections in critically ill patients is uniquely challenging because of diverse disease states, high rates of antimicrobial resistance, pharmacokinetic changes, and a high risk of mortality that leaves little margin for error. Optimal management requires balancing early, appropriate antimicrobial therapy with risks of toxicity and resistance. To do so, clinicians must integrate microbiologic diagnostics, pathogen epidemiology, patient-specific risk factors, and local resistance rates with an understanding of antimicrobial agents' spectrum and pharmacologic properties and patients' altered pharmacokinetics and pharmacodynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA; Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
- Department of Pharmacy, Brigham and Women's Hospital, Boston, MA, USA.
- Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, US…
Förderung
- Centers for Disease Control and Prevention
- Agency for Healthcare Research and Quality
Zitieren
APA
Gillett, E. M., Dube, K. M., & Rhee, C. (2026). Antibiotic Considerations in the Critically Ill. Critical Care Clinics, 42(3), 585-609. https://doi.org/10.1016/j.ccc.2026.01.003
Vancouver
Gillett EM, Dube KM, Rhee C. Antibiotic Considerations in the Critically Ill. Critical Care Clinics. 2026;42(3):585-609. doi:10.1016/j.ccc.2026.01.003
BibTeX
@article{Gillett2026,
author = {Gillett, Eric M and Dube, Kevin M and Rhee, Chanu},
title = {Antibiotic Considerations in the Critically Ill},
journal = {Critical Care Clinics},
year = {2026},
volume = {42},
number = {3},
pages = {585--609},
doi = {10.1016/j.ccc.2026.01.003}
}
EUVIMED